{"schema_version":"1","generated_at":"2026-11-18T02:51:21.766Z","data_as_of":"2026-11-13","url":"https://www.findmykol.com/kol/ezra-cohen","json_url":"https://www.findmykol.com/kol/ezra-cohen/profile.json","record_kind":"full","profile_kind":"clinical","person":{"slug":"ezra-cohen","name":"Ezra Cohen","credential":"MD","title":"Chief Medical Officer at Tempus Labs Inc.","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Melanoma","therapeutic_areas":["Melanoma","Gastrointestinal","Oncology"],"institution":"UC San Diego Health","institution_url":"https://www.findmykol.com/institution/university-of-california-san-diego","city":"San Diego","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"},"country":{"name":"United States","code":"US","status":"verified"}},"identifiers":{"npi":"1518029065"},"summary":"Ezra Cohen is Chief Medical Officer at Tempus Labs Inc. at UC San Diego Health. ClinicalTrials.gov lists 17 registered studies with this person as an investigator.","overview":{"text":"Ezra Cohen, MD, is Chief Medical Officer at Tempus Labs Inc. at UC San Diego Health. It also documents an investigator role on 17 registered clinical trials, industry payments reported by 27 companies, 5 NIH-funded awards (2017–2023).","bullets":["Top research focus: Head & Neck Cancer","17 registered trials on ClinicalTrials.gov","Open Payments reporting from 27 companies"],"generated_at":"2026-11-17"},"focus":{"indications":[{"label":"Head & Neck Cancer","therapeutic_area":"Oncology","trials":7,"topics":0,"strength":21},{"label":"Carcinoma, Squamous Cell","therapeutic_area":"Oncology","trials":6,"topics":0,"strength":18},{"label":"Melanoma","therapeutic_area":"Oncology","trials":2,"topics":0,"strength":6},{"label":"Esophageal Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Gastroesophageal Cancer","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3},{"label":"Gastrointestinal Neoplasms","therapeutic_area":"Oncology","trials":1,"topics":0,"strength":3}],"research_topics":["Head & Neck Cancer","Carcinoma, Squamous Cell","Melanoma","Esophageal Neoplasms","Gastroesophageal Cancer","Neoplasm Metastasis"],"drugs_studied":{"total":11,"shown":3,"withheld":8,"rows":[{"name":"Keytruda","generic":"Pembrolizumab","trials":0,"payments":11,"publications":0,"mentions":11},{"name":"Lenvima","generic":"Lenvatinib","trials":0,"payments":6,"publications":0,"mentions":6},{"name":"Libtayo","generic":"Cemiplimab","trials":0,"payments":3,"publications":0,"mentions":3}]},"works_with":{"total":30,"shown":3,"withheld":27,"rows":[{"name":"Merck Sharp & Dohme LLC","trials":0,"payments":22,"mentions":22},{"name":"Merck KGaA","trials":0,"payments":9,"mentions":9},{"name":"Merck Sharp & Dohme Corporation","trials":0,"payments":9,"mentions":9}]}},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":17,"shown":3,"withheld":14,"matched_by":"identity-adjudicated record","rows":[{"nct":"NCT05153304","title":"Personalized Immunotherapy in Adults With Upper Gastrointestinal Tract Cancers","phase":"PHASE1/PHASE2","status":"WITHDRAWN","role":"Investigator","sponsor":"University of California, San Diego","source_url":"https://clinicaltrials.gov/study/NCT05153304","trial_url":"https://www.findmykol.com/trial/NCT05153304"},{"nct":"NCT03991741","title":"Adoptive Cell Transfer of Autologous Tumor Infiltrating Lymphocytes and High-Dose Interleukin 2 in Select Solid Tumors","phase":"PHASE1","status":"TERMINATED","role":"Investigator","sponsor":"Gregory Daniels","source_url":"https://clinicaltrials.gov/study/NCT03991741","trial_url":"https://www.findmykol.com/trial/NCT03991741"},{"nct":"NCT03795610","title":"IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma","phase":"PHASE2","status":"COMPLETED","role":"Investigator","sponsor":"Assuntina G. Sacco, MD","source_url":"https://clinicaltrials.gov/study/NCT03795610","trial_url":"https://www.findmykol.com/trial/NCT03795610"}],"source":"trials"},"payments":{"company_count":27,"program_years":{"first":2021,"last":2025},"rows_total":32,"shown":3,"withheld":29,"rows":[{"payer":"Aveo Pharmaceuticals, Inc.","program_year":2025,"amount_usd":5000,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1518029065"},{"payer":"ABBVIE INC.","program_year":2024,"amount_usd":5220.69,"payment_count":5,"source_url":"https://openpaymentsdata.cms.gov/search?query=1518029065"},{"payer":"Regeneron Pharmaceuticals, Inc.","program_year":2024,"amount_usd":3524,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1518029065"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1518029065","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cancer & immunology","share_pct":62.2,"classes_total":1,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":62.2,"drugs":[{"name":"Mekinist","share_pct":50},{"name":"Tafinlar","share_pct":50}],"max_beneficiaries":null}]},{"area":"Hormonal (systemic)","share_pct":37.8,"classes_total":1,"classes":[{"class":"l-Thyroxine","setting":"prescribed","share_pct":37.8,"drugs":[{"name":"Levothyroxine Sodium","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":5,"fiscal_years":{"first":2017,"last":2023},"rows_total":46,"shown":3,"withheld":43,"rows":[{"project":"R21EY033669","title":"Protein ticker-tapes for brain-wide neural recordings","fiscal_year":2023,"amount_usd":338000,"organization":"HARVARD UNIVERSITY","source_url":"https://reporter.nih.gov/quickSearch/R21EY033669"},{"project":"P30CA023100","title":"Protocol Review and Monitoring Committee","fiscal_year":2023,"amount_usd":183050,"organization":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","source_url":"https://reporter.nih.gov/quickSearch/P30CA023100"},{"project":"P30CA023100","title":"Solid Tumor Therapeutics","fiscal_year":2023,"amount_usd":32104,"organization":"UNIVERSITY OF CALIFORNIA, SAN DIEGO","source_url":"https://reporter.nih.gov/quickSearch/P30CA023100"}],"source":"grants"},"publications":{"total":0,"shown":0,"withheld":0,"recent":[],"source":"works"},"presence":{"mentions":{"total":4,"shown":3,"rows":[{"url":"https://iem.ucsd.edu/researchers/people/profiles/ezra-cohen.html","platform":"other","status":"verified"},{"url":"https://pmto.ucsd.edu/faculty/cohen-ezra.html","platform":"other","status":"verified"},{"url":"https://providers.ucsd.edu/details/22401/medical-oncology-cancer","platform":"other","status":"verified"}]},"verified_means":"confirmed in more than one place; provisional means found and still being confirmed"},"recognition":{"education":{"total":1,"shown":1,"rows":[{"value":"Medical degree (MD), University of Toronto","source_url":"https://providers.ucsd.edu/details/22401/medical-oncology-cancer","status":"verified","collected_at":"2026-11-13"}]},"roles":{"total":7,"shown":3,"rows":[{"value":"Editor-in-Chief, Oral Oncology","source_url":"https://providers.ucsd.edu/details/22401/medical-oncology-cancer","status":"verified","collected_at":"2026-11-13"},{"value":"Chair, National Cancer Institute (NCI) Head and Neck Cancer Steering Committee","source_url":"https://providers.ucsd.edu/details/22401/medical-oncology-cancer","status":"verified","collected_at":"2026-11-13"},{"value":"Chaired two Multidisciplinary Head and Neck Cancer Symposia","source_url":"https://providers.ucsd.edu/details/22401/medical-oncology-cancer","status":"verified","collected_at":"2026-11-13"}]},"secondary_affiliations":{"total":2,"shown":2,"rows":[{"value":"Co-Director, Hanna and Mark Gleiberman Head and Neck Cancer Center, Moores Cancer Center","source_url":"https://iem.ucsd.edu/researchers/people/profiles/ezra-cohen.html","status":"verified","collected_at":"2026-11-13"},{"value":"Co-Director, IEM Center for Engineering in Cancer, UC San Diego Health","source_url":"https://iem.ucsd.edu/researchers/people/profiles/ezra-cohen.html","status":"verified","collected_at":"2026-11-13"}]},"media":{"total":5,"shown":3,"rows":[{"value":"Research to Practice video podcast: 2022 ASCO annual meeting key abstracts in head, neck and thyroid cancers","source_url":"https://videopodcast.researchtopractice.com/head-neck-and-thyroid-cancers-key-abstracts-in-head-neck-and-thyroid-cancers-from-the-2022-asco-annual-meeting-companion-faculty-lecture","status":"provisional","collected_at":"2026-11-13"},{"value":"OncLive video: Dr. Cohen on Future Research Directions in Head and Neck Cancer (2021)","source_url":"https://www.onclive.com/view/dr-cohen-on-future-research-directions-in-head-and-neck-cancer","status":"provisional","collected_at":"2026-11-13"},{"value":"OncLive video: Dr. Cohen on Immunotherapeutic Advances in Head and Neck Cancer (2018)","source_url":"https://www.onclive.com/view/dr-cohen-on-immunotherapeutic-advances-in-head-and-neck-cancer","status":"provisional","collected_at":"2026-11-13"}]}},"similar":[{"name":"Marc Schuckit","slug":"marc-schuckit","institution":"UC San Diego Health","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/marc-schuckit","json_url":"https://www.findmykol.com/kol/marc-schuckit/profile.json"},{"name":"Aditya Bagrodia","slug":"aditya-bagrodia","institution":"UC San Diego Health","specialty":"Urology","url":"https://www.findmykol.com/kol/aditya-bagrodia","json_url":"https://www.findmykol.com/kol/aditya-bagrodia/profile.json"},{"name":"Thomas Hemmen","slug":"thomas-hemmen","institution":"UC San Diego Health","specialty":"Neurology","url":"https://www.findmykol.com/kol/thomas-hemmen","json_url":"https://www.findmykol.com/kol/thomas-hemmen/profile.json"},{"name":"Jedd Wolchok","slug":"jedd-wolchok","institution":"Weill Cornell Medicine","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jedd-wolchok","json_url":"https://www.findmykol.com/kol/jedd-wolchok/profile.json"},{"name":"Frank Hodi","slug":"frank-hodi","institution":"Dana-Farber Cancer Institute","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/frank-hodi","json_url":"https://www.findmykol.com/kol/frank-hodi/profile.json"},{"name":"Jeffrey Sosman","slug":"jeffrey-sosman","institution":"Northwestern Medical Faculty Foundation","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jeffrey-sosman","json_url":"https://www.findmykol.com/kol/jeffrey-sosman/profile.json"},{"name":"Keith Flaherty","slug":"keith-flaherty","institution":"Massachusetts General Hospital","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/keith-flaherty","json_url":"https://www.findmykol.com/kol/keith-flaherty/profile.json"}],"coverage":{"note":"An identity-adjudicated profile: every section above was checked. Where a section states a count of zero, the public record was searched and nothing was found."},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":14,"payments":29,"funding":43}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies","collected_at":"2026-11-13"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 to 2025","collected_at":"2026-11-13"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year","collected_at":"2026-11-13"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"}},"methodology_url":"https://www.findmykol.com/about#methodology"}